[摘要]"目的"對(duì)比經(jīng)耳后發(fā)際線入路腔鏡手術(shù)與傳統(tǒng)開放手術(shù)治療腮腺腫瘤的效果及護(hù)理滿意度。方法"選取2023年3月至2024年3月浙江省腫瘤醫(yī)院收治的60例腮腺腫瘤患者作為研究對(duì)象。30例患者有小瘢痕美容手術(shù)的要求,接受耳后發(fā)際線入路腔鏡腮腺腫瘤切除術(shù)為腔鏡組,剩余30例同期接受傳統(tǒng)開放手術(shù)為開放組。對(duì)比兩組患者的手術(shù)時(shí)間、術(shù)中出血量、術(shù)后引流量、術(shù)后住院時(shí)間、術(shù)后并發(fā)癥,護(hù)理滿意度及術(shù)后1個(gè)月切口滿意度的差異。結(jié)果"腔鏡組患者的術(shù)后引流量、住院時(shí)間、術(shù)后并發(fā)癥均少于開放組,兩組比較差異有統(tǒng)計(jì)學(xué)意義(Plt;0.05)。腔鏡組患者的護(hù)理滿意度及切口滿意度大于開放組(Plt;0.05)。結(jié)論"經(jīng)耳后發(fā)際線入路腔鏡手術(shù)術(shù)后恢復(fù)快,住院時(shí)間短,術(shù)后并發(fā)癥少,圍手術(shù)期優(yōu)化護(hù)理可有效提升患者滿意度,值得臨床推廣。
[關(guān)鍵詞]"腔鏡手術(shù);耳后發(fā)際入路;腮腺腫瘤
[中圖分類號(hào)]"R473.6""""""[文獻(xiàn)標(biāo)識(shí)碼]"A""""""[DOI]"10.3969/j.issn.1673-9701.2025.02.017
Observation"on"the"effect"of"endoscopic"surgery"for"parotid"gland"tumors"via"the"postauricular"hairlinenbsp;approach
ZHENG"Lanfang1,2,"ZHAO"Jiazheng3,"WANG"Lifen2,"KONG"Hui2
1.School"of"Nursing,"Zhejiang"Chinese"Medical"University,"Hangzhou"310053,"Zhejiang,"China;"2.Operating"Room,"Zhejiang"Cancer"Hospital,"Hangzhou"310022,"Zhejiang,"China;"3.Department"of"Head"and"Neck"Surgery,"Zhejiang"Cancer"Hospital,"Hangzhou"310022,"Zhejiang,"China
[Abstract]"Objective"To"compare"the"efficacy"of"endoscopic"parotidectomy"through"postauricular"incision"with"conventional"incision"parotidectomy."Methods"A"total"of"60"parotid"tumor"patients"admitted"to"Zhejiang"Cancer"Hospital"from"March"2023"to"March"2024"were"selected"as"the"study"subjects."Thirty"patients"had"the"requirement"for"small"scar"cosmetic"surgery,"and"the"endoscopic"parotid"tumor"resection"of"the"posterior"ear"were"in"endoscopic"group,"and"remaining"30"patients"underwent"traditional"open"surgery"at"the"same"period"in"open"group."Two"groups"were"compared"in"terms"of"operation"time,"intraoperative"blood"loss,"postoperative"drainage"volume,"length"of"hospital"stay,"postoperative"complications,"nursing"satisfaction,"and"incision"satisfaction"at"one"month"postoperatively."Results"Endoscopic"group"had"significantly"lower"drainage"volume,"hospital"stay,"and"postoperative"complications"than"open"group,"there"were"significant"difference"between"two"groups"(Plt;0.05)."The"nursing"satisfaction"and"incision"satisfaction"in"endoscopic"group"were"significantly"higher"than"those"in"open"group"(Plt;0.05)."Conclusion"Efficacy"of"endoscopic"parotidectomy"through"postauricular"incision"postoperative"recovery"was"faster,"the"hospitalization"time"was"shorter,"and"the"postoperative"complications"were"less."Perioperative"optimization"nursing"in"the"endoscopic"group"improved"patient"satisfaction,"which"is"worth"promoting"clinically.
[Key"words]"Endoscope"surgery;"Postauricular;"Sialadenoma
腮腺腫瘤是頭頸外科的常見(jiàn)疾病,其中80%為良性腫瘤,主要治療方法為外科手術(shù)切除。目前傳統(tǒng)的手術(shù)方式常采用耳前頜下S形切口[1-2];這種切口雖然暴露好,操作方便,但耳屏前方及頸部的瘢痕容易增生,且不易遮擋,影響美觀,給患者帶來(lái)心理負(fù)擔(dān)并影響其生活質(zhì)量[3-4]。腔鏡手術(shù)已廣泛運(yùn)用于頭頸腫瘤手術(shù)中,國(guó)內(nèi)目前尚未達(dá)成技術(shù)與切口的共識(shí)[5-7]。腮腺腫瘤手術(shù)的難點(diǎn)在于要完全移除腫瘤,同時(shí)最大程度保護(hù)面神經(jīng)、防止涎瘺等并發(fā)癥,并減少對(duì)面部美觀的破壞。本研究選取經(jīng)耳后發(fā)際腔鏡手術(shù)與傳統(tǒng)開放手術(shù)患者各30例,比較兩種手術(shù)方式的效果及護(hù)理滿意度。
1""對(duì)象與方法
1.1""研究對(duì)象
選取2023年3月至2024年3月浙江省腫瘤醫(yī)院收治的60例腮腺腫瘤患者作為研究對(duì)象。30例患者有小瘢痕美容手術(shù)的要求,行耳后發(fā)際腔鏡腮腺腫瘤切除術(shù)為腔鏡組,余30例同期進(jìn)行傳統(tǒng)開放手術(shù)為開放組。納入標(biāo)準(zhǔn):①術(shù)后病理提示腮腺良性腫瘤;②年齡gt;18歲;③腫瘤均為單發(fā),位于腮腺淺葉后下部。排除標(biāo)準(zhǔn):①合并凝血功能障礙者;②既往有頸面部放療手術(shù)史者;③合并腮腺感染者。腔鏡組患者男19例,女11例;年齡38~65歲,平均(50.07±7.93)歲;腫瘤直徑17~37mm,平均(26.47±6.46)mm。開放組患者男20例,女10例;年齡41~63歲,平均(52.07±8.11)歲;腫瘤直徑20~35mm。平均(26.13±3.62)mm。兩組患者的一般資料比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(Pgt;0.05),具有可比性。所有入選患者均簽署知情同意書,本研究經(jīng)浙江省腫瘤醫(yī)院醫(yī)學(xué)倫理委員會(huì)批準(zhǔn)[倫理審批號(hào):IRB-2024-978(IIT)]。
1.2""治療方法
開放組采用傳統(tǒng)開放手術(shù)方式。全身麻醉成功后患者取仰臥位,肩下墊枕,頭偏健側(cè)位,常規(guī)頭頸部消毒鋪巾,取患側(cè)耳前及頜下S形切口,切開皮膚、皮下組織,沿腮腺咬肌筋膜解剖并分離皮瓣,解剖面神經(jīng)頰支及顳支,行患側(cè)腮腺淺葉切除,沖洗術(shù)腔,徹底止血,取周圍筋膜組織瓣覆蓋并保護(hù)神經(jīng),游離左側(cè)胸鎖乳突肌,使用帶蒂胸鎖乳突肌瓣填充修復(fù)腮腺區(qū)軟組織缺損,置引流管1根,逐層關(guān)閉術(shù)腔。
腔鏡組采用經(jīng)耳后發(fā)際腔鏡手術(shù)。全身麻醉后,患者取仰臥位,肩下墊枕,頭偏健側(cè)位,常規(guī)頭頸部消毒鋪巾,在患側(cè)耳后發(fā)際線作長(zhǎng)約4cm的切口,切開皮膚、皮下組織,向前分離皮瓣,用專用腮腺手術(shù)耳后拉鉤建立手術(shù)隧道,構(gòu)建術(shù)腔,使用超聲刀沿腮腺咬肌筋膜解剖并分離皮瓣,首先解剖面神經(jīng)總干,順行解剖至下頜緣支,解剖面神經(jīng)頻支、眼支、顆支,隨擬行患側(cè)腮腺淺葉腫物切除,沖洗術(shù)腔,徹底止血,取周圍筋膜組織瓣覆蓋并保護(hù)神經(jīng),置引流管1根,逐層關(guān)閉術(shù)腔,美容縫合切口。
1.3""護(hù)理措施
開放組實(shí)施常規(guī)護(hù)理措施,包括術(shù)前健康宣傳、體位配合等。腔鏡組在此基礎(chǔ)上采取優(yōu)化護(hù)理措施。常規(guī)護(hù)理措施術(shù)前護(hù)理:a.手術(shù)前1d手術(shù)室護(hù)士到病房,向患者介紹腔鏡手術(shù)基本知識(shí)和優(yōu)點(diǎn),介紹同病種腔鏡術(shù)式的成功案例,增強(qiáng)患者手術(shù)信心。b.皮膚準(zhǔn)備:指導(dǎo)家屬剃除患側(cè)耳后區(qū)足夠頭發(fā),以保證切口消毒范圍。c.疼痛護(hù)理:針對(duì)患者術(shù)前的緊張不安,巡回護(hù)士與患者積極交流,在靜脈注射麻醉藥物之前,可先輔助麻醉醫(yī)生靜脈推注2ml的利多卡因(批準(zhǔn)文號(hào):國(guó)藥準(zhǔn)字H20057816,生產(chǎn)單位:湖南科倫制藥有限公司,規(guī)格:5ml∶0.1g),用以緩解麻醉藥物注射時(shí)血管刺激引起的疼痛。d.特殊用物準(zhǔn)備:準(zhǔn)備專用懸吊拉鉤及底座、腔鏡無(wú)菌保護(hù)套、切口美容縫合線等。②術(shù)中護(hù)理:a.巡回護(hù)士配合要點(diǎn):全身麻醉后,患者取去枕仰臥位,肩下墊枕,頭偏健側(cè)位;手術(shù)床上提前固定好專用懸吊拉鉤底座,術(shù)中隨時(shí)注意出血情況,自制的止血專用“紗布小煙卷”,及時(shí)記錄與清點(diǎn)。b.器械護(hù)士配合要點(diǎn):消毒鋪巾后,洗手護(hù)士用無(wú)菌保護(hù)套保護(hù)術(shù)中暴露切口用的專用拉鉤,協(xié)助醫(yī)生建立手術(shù)隧道,構(gòu)建術(shù)腔,并固定好拉鉤;術(shù)中自制的“紗布小煙卷”,及時(shí)告知巡回護(hù)士記錄;超聲刀切割腮腺組織時(shí),可遞濕鹽水“藍(lán)帶子”保護(hù)面神經(jīng),防止超聲刀對(duì)面神經(jīng)的熱損傷;超聲刀頭上的污漬和焦痂及時(shí)用濕鹽水巾清除,及時(shí)用碘伏棉球擦拭鏡頭,減少熱煙霧對(duì)手術(shù)視野的影響,保證成像系統(tǒng)手術(shù)視野的清晰。③術(shù)后護(hù)理:a.切口護(hù)理:協(xié)助醫(yī)生妥善固定引流管,防止扭曲脫落,術(shù)后及時(shí)觀察引流液及傷口滲血情況。b.術(shù)后訪視:術(shù)后第1天進(jìn)行訪視,查看患者傷口滲血滲液、引流液性狀,有無(wú)面神經(jīng)損傷,血腫及涎瘺等并發(fā)癥,做好相關(guān)宣教;發(fā)放滿意度調(diào)查表,收集患者對(duì)手術(shù)室護(hù)理工作的反饋意見(jiàn)。c.涎瘺預(yù)防:腮腺淺葉切除術(shù)后,有涎瘺可能,術(shù)后第2天指導(dǎo)患者進(jìn)行繃帶加壓包扎。注意包扎松緊適度,避免因包扎過(guò)緊而引起不適,確保面部血供及循環(huán)正常。d.疼痛護(hù)理:及時(shí)與患者進(jìn)行溝通,告知患者不適感是暫時(shí)性的,會(huì)逐漸消失,減輕患者焦慮。如繃帶加壓包扎過(guò)緊可適當(dāng)放松;指導(dǎo)患者咳嗽時(shí)有效按壓保護(hù)切口,減少出血及疼痛。
1.4""觀察指標(biāo)
對(duì)比兩組患者的手術(shù)時(shí)間、術(shù)中出血量、術(shù)后引流量、術(shù)后住院時(shí)間、術(shù)后并發(fā)癥、護(hù)理滿意度及術(shù)后1個(gè)月切口滿意度,術(shù)后并發(fā)癥包括面癱、涎瘺、局部血腫等。護(hù)理滿意度評(píng)價(jià)采自浙江省腫瘤醫(yī)院《護(hù)理工作滿意度調(diào)查表》,結(jié)果分為滿意、非常滿意、不滿意。滿意度=(滿意例數(shù)+非常滿意例數(shù))/總例數(shù)×100%。術(shù)后1個(gè)月切口滿意度采用數(shù)字評(píng)分系統(tǒng)(numerical"score"system,NSS)[8]進(jìn)行評(píng)估。
1.5""統(tǒng)計(jì)學(xué)方法
采用SPSS"16.0統(tǒng)計(jì)學(xué)軟件對(duì)數(shù)據(jù)進(jìn)行處理分析,計(jì)量資料以均數(shù)±標(biāo)準(zhǔn)差(")表示,組間比較采用t檢驗(yàn),計(jì)數(shù)資料以例數(shù)(百分率)[n(%)]表示,組間比較采用χ2檢驗(yàn)。Plt;0.05為差異有統(tǒng)計(jì)學(xué)意義。
2""結(jié)果
2.1""兩組患者的手術(shù)情況比較
兩組患者的手術(shù)時(shí)間、術(shù)中出血量比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(Pgt;0.05)。腔鏡組患者的術(shù)后引流量和術(shù)后住院時(shí)間少于開放組,兩組比較差異有統(tǒng)計(jì)學(xué)意義(Plt;0.05),見(jiàn)表1。
2.2""兩組患者的術(shù)后并發(fā)癥與術(shù)后切口滿意度、護(hù)理滿意度比較
開放組患者的面癱、涎瘺、局部血腫發(fā)生多于腔鏡組,差異有統(tǒng)計(jì)學(xué)意義(Plt;0.05),見(jiàn)表2。術(shù)后1個(gè)月,腔鏡組患者NSS評(píng)分(9.67±0.48)分高于開放組(7.13±0.78)分,差異有統(tǒng)計(jì)學(xué)意義(Plt;0.05)。腔鏡組患者的護(hù)理滿意度高于開放組,差異有統(tǒng)計(jì)學(xué)意義(Plt;0.05),見(jiàn)表3。
3""討論
在所有涎腺腫瘤中,腮腺腫瘤的發(fā)生率最高[9];80%的腮腺腫瘤為良性,隨著腫瘤生長(zhǎng),可出現(xiàn)面部疼痛及面神經(jīng)受壓癥狀,也有少部分良性腮腺發(fā)生惡變,外科手術(shù)是腮腺腫瘤最有效的治療方式[10]。經(jīng)耳后發(fā)際線入路腔鏡手術(shù)無(wú)需充氣,操作環(huán)境開放式,借助腔鏡機(jī)器使圖像放大,故腔鏡手術(shù)比傳統(tǒng)開放手術(shù)的視野更全面,更清晰,術(shù)者可更仔細(xì)地辨認(rèn)面神經(jīng)等解剖結(jié)構(gòu),能最大程度保護(hù)患者,避免出現(xiàn)面神經(jīng)麻痹甚至面癱[11-13]。面神經(jīng)的損傷還與電刀的刺激或熱效應(yīng)等因素有關(guān),腔鏡組使用超聲刀代替電刀分離組織血管,超聲刀熱損傷半徑小,工作溫度相對(duì)較低,面神經(jīng)損失風(fēng)險(xiǎn)較開放組低[14]。本研究腔鏡組患者的術(shù)后面癱發(fā)生少于開放組,說(shuō)明腔鏡手術(shù)在降低腮腺手術(shù)面神經(jīng)損傷方面有一定的優(yōu)勢(shì)。
此外,超聲刀具有凝固作用,術(shù)中腮腺腺管切斷后,通過(guò)超聲刀凝固,能閉鎖腮腺小葉各分支細(xì)小導(dǎo)管,使斷面良好閉合,加上術(shù)后及時(shí)加壓包扎,可大大降低術(shù)后患者的涎瘺發(fā)生率[14-15]。超聲刀還能較好地封閉血管,減少出血,腮腺組織內(nèi)有豐富的血管,在使用超聲刀切割組織及血管時(shí),超聲刀的高頻振動(dòng)可在組織中產(chǎn)生摩擦熱,使血管收縮,促進(jìn)凝血,同時(shí)使蛋白質(zhì)變性形成黏滯凝固塊,凝固塊可填塞、封閉血管達(dá)到凝血作用[16-20]。本研究腔鏡組患者術(shù)后涎瘺及術(shù)后局部血腫發(fā)生少于開放組,術(shù)后引流量和術(shù)后住院時(shí)間均少于開放組,經(jīng)耳后發(fā)際線入路腔鏡手術(shù)縮短患者住院時(shí)間,節(jié)省住院開銷,患者整體就醫(yī)滿意度提升。
傳統(tǒng)開放切口手術(shù)耳屏前方切口明顯,面部遺留較大瘢痕[21]。而經(jīng)耳后發(fā)際線入路腔鏡手術(shù)最大的優(yōu)點(diǎn)是其美容效果,因?yàn)槎蟀l(fā)際線切口隱蔽,頭發(fā)長(zhǎng)出后能完全覆蓋切口疤痕。本研究腔鏡組患者美容效果評(píng)分高于開放組,充分說(shuō)明經(jīng)耳后發(fā)際線入路腔鏡手術(shù)具有很好的美容優(yōu)勢(shì)。綜上,對(duì)病灶位于腮腺淺葉后下部的良性腮腺腫瘤,經(jīng)耳后發(fā)際線入路腔鏡手術(shù)治療效果更佳,值得臨床推廣。
利益沖突:所有作者均聲明不存在利益沖突。
[參考文獻(xiàn)]
[1] KIM"S,"PARK"J,"LEE"D."Aesthetic"considerations"innbsp;parotidectomy:"A"review"of"incision"techniques[J]."J"Oral"Maxillofac"Surg,"2022,"80(5):"1021–1030.
[2] ROH"J"L."Functional"gland-preserving"surgery"via"periauricular"incision"for"pleomorphic"adenoma"of"the"parotid"gland[J]."Eur"J"Surg"Oncol,"2022,"48(1):"21–26.
[3] ZHANG"Q,"LIU"Y,"WANG"J,"et"al."Comparison"of"cosmetic"outcomes"in"parotidectomy"using"different"incisions[J]."Front"Surg,"2021,"8:"1234–1240.
[4] 顏光堂,"王中亮,"田蓉."改良切口與傳統(tǒng)切口治療腮腺良性腫瘤的療效比較[J]."成都醫(yī)學(xué)院學(xué)報(bào),"2024,"19(3):"437–441.
[5] WOODS"A"L,"CAMPBELL"M"J,"GRAVES"C"E."A"scoping"review"of"endoscopic"and"robotic"techniques"for"lateral"neck"dissection"in"thyroid"cancer[J]."Front"Oncol,"2024,"14:"129.
[6] 王怡娟,"胡亮,"祁森榮."唾液腺內(nèi)鏡的臨床應(yīng)用[J]."北京口腔醫(yī)學(xué),"2019,"2(29):"119–121.
[7] 唐志強(qiáng),"單遠(yuǎn)洲."經(jīng)腋窩入路單孔腔鏡甲狀腺手術(shù)臨床療效分析[J]."中國(guó)現(xiàn)代手術(shù)學(xué)雜志,"2018,"22(1):"18–21.
[8] 周鵬,"徐婧,"劉永祥,"等."國(guó)產(chǎn)機(jī)器人手術(shù)系統(tǒng)在甲狀腺癌手術(shù)中應(yīng)用的安全性與療效[J]."中國(guó)普通外科雜志,"2024,"33(5):"753–761.
[9] QUER"M,"HERNANDEZ-PRERA"J"C,"SILVER"C"E,""""et"al."Current"trends"and"controversies"in"the"management"of"warthin"tumor"of"the"parotid"gland[J]."Diagnostics,"2021,"11(8):"1467.
[10] 田亮亮,"趙佳雄,"南欣榮."副腮腺腫瘤的診療研究進(jìn)展[J]."口腔醫(yī)學(xué),"2024,"44(5):"397–400.
[11] 馮鐵軍,"謝宇,"林雅琪,"等."腔鏡手術(shù)與傳統(tǒng)手術(shù)對(duì)腮腺良性腫瘤的治療效果的Meta分析[J]."南方醫(yī)科大學(xué)學(xué)報(bào),"2021,"41(3):"464–470.
[12] 劉志鋒,"江青山,"李明,"等."腔鏡下耳后發(fā)際線徑路面神經(jīng)順行解剖后腮腺良性腫瘤切除術(shù)的臨床分析[J]."中國(guó)耳鼻咽喉顱底外科雜志,"2023,"29(6):"86–88.
[13] 劉洪,"李超,"樊晉川,"等.nbsp;腮腺手術(shù)切除術(shù)中兩種解剖方式對(duì)面神經(jīng)功能的影響[J]."中國(guó)腫瘤臨床,"2014,"41(17):"1120–1124.
[14] 孫明星,"趙軍方."超聲刀與單極電刀在腮腺淺葉切除術(shù)患者的臨床效果評(píng)價(jià)[J].罕少疾病雜志,2021,"28(3):"31–33.
[15] 宋建忠,"任文豪,"高嶺,"等."超聲刀在腮腺淺葉腫瘤改良術(shù)中的臨床應(yīng)用[J]."實(shí)用口腔醫(yī)學(xué)雜志,"2019,"35(6):"810–813.
[16] 顧占國(guó),石福民,翟健,"等."超聲刀聯(lián)合美容切口對(duì)腮腺腫瘤手術(shù)面神經(jīng)的保護(hù)作用[J]."河北醫(yī)科大學(xué)學(xué)報(bào),"2020,"41(2):"154–162.
[17] 周健."超聲高頻集成技術(shù)的優(yōu)勢(shì)及臨床應(yīng)用價(jià)值[J]."中國(guó)醫(yī)療設(shè)備,"2021,"36(5):"157–160.
[18] HASANI"Z,"ABEDINI"R."Effect"of"ultrasonic"scalpel"parameters"on"vessel"sealing"and"thermal"effects[J]."Modares"Mech"Eng,"2024,"24(4):"259–267.
[19] 王友元,"袁開放."內(nèi)窺鏡輔助下經(jīng)耳后溝切口切除不同區(qū)域腮腺腫瘤的療效評(píng)估[C]."2019第一屆全國(guó)口腔頜面+頭頸腫瘤學(xué)術(shù)大會(huì)——聚合引領(lǐng)?協(xié)同發(fā)展論文匯編,"2019.
[20] SMILEY"K"E,"WURAOLA"F,"MOJIBOLA"B"O,"et"al."An"outcomes-focused"analysis"of"laparoscopic"and"open"surgery"in"a"Nigerian"hospital[J]."J"Soc"Laparoscop"Rob"Surg,"2023,"27(1):"e2022.
[21] 馬仕昆,"張媞,"胡玥,"等."胸乳入路腔鏡手術(shù)治療甲狀腺良性腫瘤的臨床應(yīng)用[J]."中國(guó)普通外科雜志,"2022,"31(5):"692–697.
(收稿日期:2024–08–02)
(修回日期:2024–11–23)